Jefferson Capital Inc Dossier - Source-backed chat

Jefferson Capital Inc

JCAPNASDAQ

SectorFinancials

IndustryCredit Services

Beta (adjusted)1.00

Intrinsic Value

Insufficient data for a value estimateNot enough reliable inputs to publish a fair value for this company yet.

Market Price $19.14Price as of 1 Oct 2026

Data confidence Sign in to view data confidence

Market Cap $1.1B

Enterprise Value $2.5B

Shares Outstanding 51.9M diluted

Next Earnings Date16 Nov 2026

Last ex-dividend24 Aug 2026

All prices and values are periodic snapshots, not live quotes. Source dates are shown for reference.

Thesis

Street consensus, scenarios, merits, risks, and invalidation triggers

AI-assisted

Thesis Summary

Jefferson Capital, Inc. (NASDAQ: JCAP) is a leading analytically driven purchaser and manager of dislocated consumer credit portfolios. The company is uniquely positioned to capitalize on a highly favorable macroeconomic backdrop characterized by near-record consumer debt levels and elevated delinquencies. Jefferson Capital stands out from its peers due to its sector-leading cash efficiency, disciplined balance sheet management (leverage at 1.79x, well below its long-term target of 2.0x-2.5x), and shorter-duration portfolio. Recent strategic acquisitions, such as the Bluestem Brands credit card portfolio, provide strong growth momentum for 2026. While the stock has experienced near-term pressure due to secondary offerings by its private equity sponsor, J.C. Flowers, this overhang is expected to dissipate over time, unlocking significant public float, trading liquidity, and valuation upside.

This section is the 12-month view: analyst targets and the probability-weighted scenarios built from them. The intrinsic value at the top of this page answers a different question: what the business is worth today.

Street view · analyst 12-month targets5 analysts · as of 18 Aug 2026

Low · most bearish analyst$24.00

Mean target$27.80

High · most bullish analyst$30.00

Our research · scenarios, merits, risks, and invalidation triggersResearch as of 18 Sep 2026

Scenarios · 12-month scenario targetsAnchored at research date

Bear CaseDownside scenario

$24.0020%

A sharp macroeconomic downturn or spike in unemployment severely impairs the repayment capacity of distressed consumers, leading to lower-than-expected collections and write-downs of ERC. Operating expenses continue to surge due to high legal collection costs, compressing net margins. The persistent overhang of J.C. Flowers' majority stake continues to depress the stock price.

Base CaseCentral scenario

$27.8050%

Matches the consensus mean

The company maintains steady portfolio deployments of $150M-$200M per quarter at attractive returns. Collections grow in line with an 18% ERC expansion, and the Cash Efficiency Ratio stabilizes around 70-73%. Operating expenses remain elevated but are offset by robust top-line growth. J.C. Flowers continues its orderly sell-down, and the stock gradually rerates as liquidity improves.

Bull CaseUpside scenario

$30.0030%

Underwriting conditions remain highly favorable with elevated charge-offs providing a steady supply of cheap portfolios. Shorter-duration collections outperform expectations, and the integration of the Bluestem portfolio delivers higher-than-expected cash flows. Operating leverage improves as collection platforms scale, driving significant margin expansion. Public float increases rapidly as J.C. Flowers exits in an orderly manner, attracting institutional investors and driving multiple expansion toward historical peer averages.

Scenarios are anchored to street consensus at the research date, with our probabilities and rationale.

Key Investment Merits

Sector-leading Cash Efficiency Ratio of 73.0% as of Q1 2026, driven by sophisticated proprietary data modeling and neural networks.
Strong balance sheet with a leverage ratio of 1.79x, which is below the company's long-term target range of 2.0x-2.5x, providing ample capacity for opportunistic deployments.
Favorable countercyclical demand backdrop with elevated consumer credit delinquencies and charge-offs creating a robust pipeline of portfolio supply.
Shorter-duration portfolio compared to peers due to lower average account balances, enabling faster cash recycling and lower interest rate risk.

Key Investment Risks

Significant near-term margin compression and net income decline due to rapidly rising operating expenses (+47% YoY in Q1 2026).
Sponsor overhang risk, as J.C. Flowers still controls approximately 53% of the common stock, which can create technical selling pressure during secondary offerings.
Sensitivity to macroeconomic indicators, particularly the unemployment rate, which directly impacts consumer liquidation and collection rates.
Regulatory and compliance risks associated with consumer debt collection practices and data privacy laws.

Thesis Invalidation Triggers

A sustained rise in the US unemployment rate above 5.5%, which would severely impair collection rates on the existing book.
A drop in the Cash Efficiency Ratio below 65.0% for two consecutive quarters.
Failure to integrate or achieve projected collections on the newly acquired Bluestem Brands portfolio.
Material regulatory actions or fines from consumer protection agencies regarding collection practices.

All scenarios are estimates and subject to change. Past performance is not indicative of future results.

Quality Pillars Members

This section is available to registered members. Create a free account or sign in to unlock the full breakdown.

Explore this dossier

ValuationIntrinsic value, the six-method breakdown, peer medians, and your assumptions sandbox.Financial SnapshotRevenue, profitability, returns, balance sheet, dividends, and the filing-level detail.Qualitative AnalysisBusiness overview, strategic initiatives, and mergers, acquisitions & partnerships.Outlook & Key DatesForward estimates, reporting calendar, and the monitoring framework.